Tehran University of Medical Sciences

Science Communicator Platform

Share By
Conditioned Media Derived From Mesenchymal Stem Cells Induces Apoptosis and Decreases Cell Viability and Proliferation in Squamous Carcinoma Cell Lines Publisher Pubmed



Bagheri R1, 2 ; Bitazar R1 ; Talebi S3 ; Alaeddini M1 ; Etemadmoghadam S1 ; Eini L4
Authors

Source: Gene Published:2021


Abstract

Squamous cell carcinoma (SCC) is a relatively common cancer with a low survival rate, poor prognosis and no effective treatment strategy. The use of cell-free conditioned media derived from mesenchymal stem cells (CM-MSCs) has shown promising results in treating various diseases. This study aimed to evaluate the effects of CM-MSCs on proliferation and apoptosis of CAL-27 and FaDu SCC cell lines. CM derived from human bone marrow and human amniotic membrane MSCs (BM-MSCs and AM-MSCs) was used in this investigation. MTT assay demonstrated that CM-BMMSC decreased the viability of CAL-27 and FaDu cell lines, 24, 48, and 72 h after treatment. Quantitative real-time PCR indicated that mRNA expression of PCNA as a proliferative marker, and BCL-2 as an anti-apoptotic protein, decreased in both cell lines treated with CM-BMMSC. Based on the flow cytometry results, the number of positive proliferative Ki67 cells and apoptotic Annexin-V cells decreased and increased in both cell lines treated with CM-BMMSC, respectively. However, CM-AMMSC treatment had both pro-and anti-neoplastic effects in our samples and showed considerable differences between the two cell lines. Taken together, our findings demonstrated that CM-BMMSC and, to a lesser degree, CM-AMMSC decrease cell viability and proliferation and increase cell apoptosis in SCC cell lines in a time-dependent manner. However, further studies are needed, especially to evaluate the anti-tumor potential of CM-BMMSC in vivo. © 2021 Elsevier B.V.
Other Related Docs
16. Enhancement of the Sensitivity of the Acute Lymphoblastic Leukemia Cells to Abt-737 by Formononetin, International Journal of Molecular and Cellular Medicine (2024)